Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism GPR183 antagonists(G protein-coupled receptor 183 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H20BrClN2O |
InChIKeyNXTNVQJKGHAGAX-BJMVGYQFSA-N |
CAS Registry1597489-14-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | United States | 16 Jan 2015 |